BlackRock Institutional Trust’s Windtree Therapeutics Inc WINT Stock Holding History

BlackRock Institutional Trust’s Portfolio WINT Stock Details WINT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$238K	Hold	190,106	–	–	﹤0.01%	3569
2016 Q3	$487K	Hold	190,106	–	–	﹤0.01%	3487
2016 Q2	$367K	Hold	190,106	–	–	﹤0.01%	3553
2016 Q1	$317K	Sell	190,106 -4	-0%	-$9	﹤0.01%	3544
2015 Q4	$569K	Hold	190,110	–	–	﹤0.01%	3482
2015 Q3	$798K	Buy	190,110 +2,578	+1%	+$17.1K	﹤0.01%	3403
2015 Q2	$1.78M	Buy	187,532 +2,959	+2%	+$41.5K	﹤0.01%	3162
2015 Q1	$3.08M	Buy	184,573 +4,475	+2%	+$88.1K	﹤0.01%	2935
2014 Q4	$2.92M	Buy	180,098 +451	+0.3%	+$9.92K	﹤0.01%	2949
2014 Q3	$4.63M	Buy	179,647 +10,796	+6%	+$261K	﹤0.01%	2725
2014 Q2	$4.21M	Buy	168,851 +10,127	+6%	+$259K	﹤0.01%	2862
2014 Q1	$4.78M	Buy	158,724 +26,731	+20%	+$899K	﹤0.01%	2804
2013 Q4	$4.16M	Buy	131,993 +19,956	+18%	+$624K	﹤0.01%	2867
2013 Q3	$3.07M	Buy	112,037 +2,648	+2%	+$64.2K	﹤0.01%	2938
2013 Q2	$2.33M	Buy	+109,389	New	+$2.69M	﹤0.01%	3008

Other funds holding WINT

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

SFWA

Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return

BlackRock Institutional Trust's WINT Position: Q4 2016 in Review

BlackRock Institutional Trust held its Windtree Therapeutics Inc (WINT) position steady in Q4 2016 at 190,106 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

BlackRock Institutional Trust first reported a position in WINT in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.78M in Q1 2014. 31 funds tracked by Wall St. Rank hold WINT as of Q4 2016.

BlackRock Institutional Trust held 190,106 shares of Windtree Therapeutics Inc worth $238K as of Q4 2016.
BlackRock Institutional Trust left its Windtree Therapeutics Inc share count unchanged in Q4 2016.
Windtree Therapeutics Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3569 holding.
BlackRock Institutional Trust first reported a position in Windtree Therapeutics Inc in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Windtree Therapeutics Inc position peaked at $4.78M in Q1 2014.
31 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.